The company has filed an Investigational New Drug (IND) Application with the United States Food &Drug Administration and plans to seek Fast-Track designation for treating chronic hepatitis C.

• 公司提出了一个调查新药物(IND) 申请与美国食物& 药物管理和计划寻找快速轨道指定为对待的慢性丙型肝炎。